Last reviewed · How we verify

NCT03576027

Hyperbaric Oxygen Therapy in Children With Inflammatory Bowel Diseases

Status unknown NA Last updated 20 May 2020
What this trial tests

NA trial testing Hyperbaric Oxygen Therapy in Inflammatory Bowel Diseases in 30 participants. Status unknown.

Timeline
21 May 2018
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorMedical University of Warsaw
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date21 May 2018
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Warsaw

Who can join

Adults 5 to 18, any sex, with Inflammatory Bowel Diseases or Children, Only. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study assesses the effectiveness of hyperbaric oxygen therapy in the treatment of inflammatory bowel disease in children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hyperbaric Oxygen Therapy

Trials testing the same drug.

Other recruiting trials for Inflammatory Bowel Diseases

Currently open trials in the same condition.

Other Medical University of Warsaw trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03576027.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing